A few things: some of which has been addressed.
Marijuana and CBD are two completely different things even thought they are both derived from the cannabis plant. One is the Marijuana(not technical) plant and the other is the Hemp plant. The Marijuana plant produces THC(makes you high) the hemp plant produces CBD(does not). Both plants can produce trace amounts of the chemical desired in the other.
The highest and purist grade CBD oil has no THC in it and the people whom use it for medicinal purposes do not want the THC. In fact CBD grade hemp is tested throughout the growing and processing process and if it is found to have more than .03% THC content it is considered flawed and is usually destroyed in areas where pot is illegal. There are now strains with 0% THC
CBD has been found to help with the issues below along with a number of other ailments. Again the purest form of CDB has no psychoactive properties and looks to be on the threshold of being useful in a number of different ways. What it wont be useful for is getting you high. It was legalized by the most recent farm Bill last year so it covers most of the concerns you mention below.
The biggest relief of course is with those with the severe epileptic seizures and a dramatic reduction in frequency.
as a side note one of the most successful Hemp farmers in South Carolina is our own Danny Ford.
And the hits just keep coming... Showing what an absolutely moronic stance our very own FDA is taking by keeping Marijuana as a Schedule I drug (No acceptable medical uses).
Clinical Study in the American Journal of Psychiatry suggests that CBD oil reduces the effects of Heroin use:
Clinical Study in the American Journal of Psychiatry suggests that CBD oil reduces the effects of Heroin use:
Click (
@orangelvis : Primary Source)
FYI, I work at a university and have access to a TON of journals. I have no idea if this one can be viewed by the public or not. Here's and cut and paste from the Abstract just in case.
Methods:
This exploratory double-blind randomized placebo-controlled trial assessed the acute (1 hour, 2 hours, and 24 hours), short-term (3 consecutive days), and protracted (7 days after the last of three consecutive daily administrations) effects of CBD administration (400 or 800 mg, once daily for 3 consecutive days) on drug cue–induced craving and anxiety in drug-abstinent individuals with heroin use disorder. Secondary measures assessed participants’ positive and negative affect, cognition, and physiological status.
Results:
Acute CBD administration, in contrast to placebo, significantly reduced both craving and anxiety induced by the presentation of salient drug cues compared with neutral cues. CBD also showed significant protracted effects on these measures 7 days after the final short-term (3-day) CBD exposure. In addition, CBD reduced the drug cue–induced physiological measures of heart rate and salivary cortisol levels. There were no significant effects on cognition, and there were no serious adverse effects.
Conclusions:
CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.[/QUOTE]